Quest Partners with Pennsylvania-Based Healthcare System
Quest Diagnostics partnered with the regional integrated healthcare system in Pennsylvania to help enhance its diagnostic services.
Read MorePosted by Andy Lundin | Feb 20, 2023 | Company News |
Quest Diagnostics partnered with the regional integrated healthcare system in Pennsylvania to help enhance its diagnostic services.
Read MorePosted by Andy Lundin | Feb 14, 2023 | Prostate |
This model combines profiles of fusion genes in prostate cancer with the Gleason score and prostate-specific antigen (PSA) level.
Read MorePosted by Andy Lundin | Feb 13, 2023 | Prostate |
Cleveland Diagnostics announced an agreement with Quest Diagnostics to expand patient access to its novel prostate cancer test, IsoPSA.
Read MorePosted by Andy Lundin | Feb 10, 2023 | Prostate |
LynxDx is introducing a non-invasive, data-driven, urine prostate cancer screening test to guide clinical decisions for patients.
Read MorePosted by Andy Lundin | Feb 8, 2023 | Prostate |
Researchers at the University of East Anglia helped develop a blood test to detect prostate cancer with greater accuracy than current methods.
Read More